Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology

Patent metadata

Field	Value
Publication number	US-11504408-B2
Application number	US-201916976952-A
Country	US
Kind code	B2
Filing date	Mar 15, 2019
Priority date	Mar 15, 2018
Publication date	Nov 22, 2022
Grant date	Nov 22, 2022

Abstract

A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum, and combinations thereof is also provided.

First claim

What is claimed is:

1. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease, the probiotic composition comprising:
a bacterial component that is a combination of Bacteroides acidifaciens and Bifidobacterium choerinum such that the Bifidobacterium choerinum enhances probiotic activity of Bacteroides acidifaciens to be administered for prevention and treatment of gastrointestinal autoimmune and/or inflammatory disease; and
a protective component that stabilizes the bacterial component.

2. The probiotic composition of claim 1 wherein the bacterial component further comprises gut microbiota strains isolated from genera selected from the group consisting of Lactobacillus, Allobaculum, Bifidobacterium , and combinations thereof.

3. The probiotic composition of claim 2 wherein each bacterial component is present in an amount from about 10 3 to about 10 14 CFU/g of each bacterial component.

4. The probiotic composition of claim 1 wherein the protective component is selected from the group consisting of protective carriers, protective coating, and protective encapsulants.

5. The probiotic composition of claim 1 wherein the protective component is a liquid.

6. The probiotic composition of claim 5 wherein the liquid is a hydroxylated hydrocarbon carrier.

7. The probiotic composition of claim 5 wherein the liquid is a polyol.

8. The probiotic composition of claim 1 wherein the protective component includes a stabilization agent that interacts with or encapsulates the bacterial component.

9. The probiotic composition of claim 8 wherein the stabilization agent is selected from the group consisting of adonitol, betaine, carbohydrates, proteins, amino acids, mixtures of sugar and protein, gums and skim milk, and combinations thereof.

10. The probiotic composition of claim 9 wherein the stabilization agent is dissolved or dispersed in a liquid.

11. The probiotic composition of claim 1 wherein the protective component encapsulates the bacterial component.

12. The probiotic composition of claim 11 wherein the bacterial component is encapsulated by spray drying, fluidized bed drying, or vacuum drying.

13. The probiotic composition of claim 11 wherein the protective component includes an encapsulating agent selected from the group consisting of maltodextrins, skim milk, reconstituted skim milk, casein, soybean protein, trehalose, and combinations thereof.

14. The probiotic composition of claim 1 further comprising an additive selected from the group consisting of any suitable adjuvants, excipients, additives, additional therapeutic agents, bioavailability enhancers, side-effect suppressing components, diluents, buffers, flavoring agents, binders, preservatives or other ingredients and combinations thereof.

15. The probiotic composition of claim 1 incorporated into a capsule.

Assignees

• Univ Southern California

Inventors

• Longo Valter D
• Wei Min
• Rangan Priya

Classifications

• A61K35/747 Primary

  Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title

• A61K9/48

  Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)} · CPC title

• A61K35/741 Primary

  Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06) · CPC title

• A61K35/745

  Bifidobacteria · CPC title

• A23L19/01

  Instant products; Powders; Flakes; Granules (A23L19/10 – A23L19/12 take precedence) · CPC title